Evaluating serum free light chain ratio as a biomarker in multiple myeloma
Haematologica
.
2024 Oct 3.
doi: 10.3324/haematol.2024.285531.
Online ahead of print.
Authors
Theresia Akhlaghi
1
,
Kylee Maclachlan
2
,
Neha Korde
2
,
Sham Mailankody
2
,
Alexander Lesokhin
2
,
Hani Hassoun
2
,
Sydney X Lu
2
,
Dhwani Patel
2
,
Urvi Shah
2
,
Carlyn Tan
2
,
Andriy Derkach
3
,
Oscar Lahoud
4
,
Heather J Landau
4
,
Gunjan L Shah
4
,
Michael Scordo
4
,
David J Chung
4
,
Sergio A Giralt
4
,
Saad Z Usmani
2
,
Ola Landgren
5
,
Malin Hultcrantz
6
Affiliations
1
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. theresia.akhlaghi@gmail.com.
2
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
3
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
4
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
5
Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
6
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. hultcram@mskcc.org.
PMID:
39363855
DOI:
10.3324/haematol.2024.285531
Abstract
Not available.